This expands the clinical phenotype spectrum of GABRG2 mutations in epilepsy and further strengthens the notion of overlapping clinical phenotypes between GABRG2, GABRB3, and possibly other GABR mutations. This evidence concerns the gene GABRG2 and epilepsy.